Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 19, 2020 (6 years ago)

Zilretta (triamcinolone acetonide extended-release injectable suspension)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded

Cause type: Temperature excursion

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled. All temperature excursion recalls.

What was recalled

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01

Affected NDC 70801-0003-01

Compare with the code on your package — it is the most precise check available.

Drug: Triamcinolone

Recalling firm
Flexion Therapeutics, Inc.
NDC code
70801-003-01
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1376-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Triamcinolone recalls

See all
Class II · Moderate risk

Testosterone 200mg

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0329-2026
Class II · Moderate risk

Testosterone 100mg

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0328-2026

Other temperature excursion recalls from 2020

All temperature excursion recalls
Class III · Low risk

Famotidine Injection

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Terminated Temperature excursion HF Acquisition Co. LLC NDC 63323-739-12 D-1392-2020